Skip to main content

Table 1 Included Population description

From: Prognostic value of estimated glomerular filtration rate in hospitalised older patients (over 65) with COVID-19: a multicentre, European, observational cohort study

 

Alive

(N = 1060)

Dead

(N = 742)

Total

(N = 1802)

N (%)

N (%)

N (%)

eGFR

 1–29

92 (46.5)

106 (53.5)

198 (11.0)

 30–44

153 (51.7)

143 (48.3)

296 (16.4)

 45–59

176 (57.3)

131 (42.7)

307 (17.0)

 60+

600 (64.0)

337 (36.0)

937 (52.0)

 Missing

39

25

64

Wave

 1

765 (58.0)

553 (42.0)

1318 (73.1)

 2

295 (61.0)

189 (39.0)

484 (26.9)

Age

 65–74

362 (68.8)

164 (31.2)

526 (29.2)

 75–84

431 (57.2)

322 (42.8)

753 (41.8)

 85–94

247 (51.8)

230 (48.2)

477 (26.5)

 95+

20 (43.5)

26 (56.5)

46 (2.6)

Sex

 Female

509 (62.9)

300 (37.1)

809 (44.9)

 Male

550 (55.4)

442 (44.6)

992 (55.0)

Missing

1

0

1

Smoking

 Never Smokers

515 (60.8)

332 (39.2)

847 (47.0)

 Ex-smokers

444 (55.7)

353 (44.3)

797 (44.2)

 Current Smokers

67 (65.0)

36 (35.0)

103 (5.7)

Missing

34

21

55

Diabetes

 No

764 (59.4)

522 (40.6)

1286 (71.4)

 Yes

294 (57.4)

218 (42.6)

512 (28.4)

Missing

2

2

4

Hypertension

 No

452 (57.4)

335 (42.6)

787 (43.7)

 Yes

181 (61.1)

115 (38.9)

296 (16.4)

 Yes & on treatment

427 (59.4)

292 (40.6)

719 (39.9)

CAD

 No

807 (60.4)

528 (39.6)

1335 (74.1)

 Yes

252 (54.4)

211 (45.6)

463 (25.7)

Missing

1

3

4

CRP

 0–40

401 (69.4)

177 (30.6)

578 (32.1)

  > 40

659 (53.8)

565 (46.2)

1224 (67.9)

CFS

 CFS 1–3

283 (71.1)

115 (28.9)

398 (22.1)

 CFS 4

157 (59.5)

107 (40.5)

264 (14.7)

 CFS 5–6

368 (57.4)

273 (42.6)

641 (35.6)

 CFS 7–8

227 (50.9)

219 (49.1)

446 (24.8)

 CFS 9

9 (29.0)

22 (71.0)

31 (1.7)

Missing

16

6

22